On 20 April 2026, the European Chemicals Agency (ECHA) officially added 12 substances to the Candidate List of Substances of Very High Concern (SVHC), among which 2 organophosphorus compounds and 1 nitrogen-containing heterocyclic compound are highly similar in molecular structure and coordination properties to ligands commonly used in the production of amino acid chelates. This adjustment directly affects Chinese exporters of amino acid chelate compounds to the EU market, and creates substantial compliance pressure especially for niche sectors such as fine chemicals, feed additives, fertilizer auxiliaries, and cosmetic active ingredients that rely on chelation technology.

Event Overview

On 20 April 2026, the European Chemicals Agency (ECHA) issued an update adding 12 substances to the SVHC Candidate List. According to ECHA’s official announcement, the newly added substances include 2 organophosphorus compounds and 1 nitrogen-containing heterocyclic compound. Although these substances are not directly listed as finished amino acid chelating agents, their structural characteristics are highly similar to the key ligand units involved in the metal coordination process of common amino acid derivatives such as glycine, glutamic acid, and lysine. This list update has taken effect, and the related notification, SCIP database submission, and supply chain information communication obligations are triggered from the date of listing.

Which market segments are affected

Direct trading enterprises

Companies engaged in exporting amino acid chelates (such as ferrous glycinate, zinc methionine, and copper lysinate) to Europe will face mandatory SVHC notification obligations. If the content of any newly added SVHC in a product exceeds 0.1% (mass fraction), and the total annual export volume exceeds 1 tonne, notification to ECHA is required; at the same time, accurate registration in the SCIP database must be ensured. Failure to comply may result in customs clearance delays or return shipment of goods.

Raw material procurement enterprises

Companies purchasing intermediates containing organophosphorus or nitrogen-containing heterocyclic structures (such as HEDP, ATMP, and BTA) for chelation reactions need to reassess whether upstream raw materials introduce SVHC substances. Because some ligand synthesis routes may leave residues of or coexist with structurally similar impurities, the absence of SVHC declarations in raw material specifications and COA will become a supply chain risk point.

Processing and manufacturing enterprises

Manufacturers that use amino acids as starting materials and prepare metal chelates through complexation reactions need to verify whether the current process routes use or generate any of the SVHC substances included in this listing. In particular, production lines using phosphonate catalysts, buffers, or stabilizers should carry out Substance Flow Analysis to identify potential SVHC introduction points.

Supply chain service enterprises

Third-party organizations providing services such as SDS preparation, label review, SCIP filing agency, and compliance training need to update database templates and assessment logic accordingly. Current SVHC list matching rules need to be expanded to cover structural similarity at the ligand level, rather than being limited only to finished substance names, which places higher requirements on consistency review of technical documentation.

Key points companies or practitioners should focus on, and how to respond at present

Immediately launch a thorough screening of SVHC components in existing products

Based on the CAS numbers and structural formulas of the 12 SVHC substances published by ECHA, compare them item by item against your own product formulations, synthetic intermediates, by-products, and raw material impurity profiles. Focus especially on whether ligand synthesis routes involve reaction steps such as phosphonylation and cyclocondensation that may generate structurally similar substances.

Simultaneously update the technical compliance documentation system

For all amino acid chelates exported to Europe, revisions to Section 3 (composition information) and Section 15 (regulatory information) of the SDS must be completed within Q2 2026; labels must be supplemented with SVHC identification in accordance with CLP requirements (where applicable); and technical agreements for all newly signed orders should incorporate SVHC declaration clauses and clearly define responsibility boundaries.

Assess changes in downstream customer entry requirements

EU downstream users (such as feed enterprises, fertilizer manufacturers, and cosmetic OEMs) have successively launched supplier SVHC compliance questionnaires. Companies are advised to prepare SVHC screening reports, substance declaration letters, and process description documents in advance to avoid order suspension or qualification downgrading due to delayed responses.

Continue tracking the release of subsequent ECHA implementation guidance

ECHA has not yet issued detailed guidance on “whether structurally similar substances trigger notification obligations.” Current notification obligations are still based on the substances specifically listed on the list itself, but industry observers believe that future enforcement may strengthen traceability review of ligand functional units. Companies should subscribe to ECHA’s official notification channels and focus on updates to the Questions and Answers on SVHC Notification (Version 5) expected to be released in the second half of 2026.

Editor’s View / Industry Observation

From an industry perspective, this SVHC list update is more like a structural early warning signal than an immediately enforceable comprehensive ban. It reflects that ECHA is gradually extending its review dimension from end-substance regulation to reaction mechanisms and the essence of coordination chemistry. Analysis shows that the regulatory focus is no longer limited to “whether it is contained,” but is paying more attention to “whether it can be generated / whether it has the same biological coordination behavior.” What deserves more attention at present is that although suppliers with HACCP and ISO certification have advantages in quality systems, their existing compliance frameworks may not necessarily cover the assessment logic for SVHC structural similarity, and system adaptation requires dedicated upgrading. It is more appropriate to understand this as a “compliance capability stress test” for exporters of chelation technology, testing their ability to understand regulations at the molecular level.

Conclusion
This expansion of the REACH SVHC list marks that EU regulation of metal chelate chemicals has entered a structure-oriented stage. Its industry significance lies not in the number of newly added substances themselves, but in the release of a new model of “defining regulatory boundaries by coordination functions.” Rationally speaking, companies do not need to overreact, but they must abandon the traditional compliance path that relies only on finished product testing and shift to full-chain substance management covering raw materials, intermediates, reaction routes, and impurity profiles. At present, it is more appropriate to regard this adjustment as a pre-emptive compliance calibration opportunity rather than a sudden risk event.

Information source note
Main source: official announcement on the European Chemicals Agency (ECHA) website (SVHC Candidate List update document dated 20 April 2026).
Items requiring continued observation: whether ECHA will issue binding notification interpretation guidance on “structurally similar substances”; and changes in the actual inspection scope of customs authorities in EU member states for products containing similar ligands.